Major Rating Factors:
Poor long-term capitalization index (0.0 on a scale of 0 to 10) based on weak current risk adjusted capital (severe and moderate loss scenarios). Weak overall results on stability tests (0.0) including weak risk adjusted capital in prior years, weak risk diversification and weak results on operational trends. The largest net exposure for one risk is excessive at 54.8% of capital. Fair reserve development (3.7) as reserves have generally been sufficient to cover claims. In 2020 the two year reserve development was 28.2% deficient.
Other Rating Factors:
Good overall profitability index (6.2) despite operating losses during 2022 and the first six months of 2025. Return on equity has been good over the last five years, averaging 11.6%. Superior liquidity (10.0) with ample operational cash flow and liquid investments.
Stability Factors:
C - Past results on our Risk-Adjusted Capital tests.
D - Limited diversification of general business, policy, and/or investment risk.
T - Significant trends in critical asset, liability, income or expense items.
Principal Lines of Business:
Med mal (100.0%)
Licensed in:
SC
Principal Investments:
Investment grade bonds (40.7%), common stock (39.3%), cash (20.0%)
Corporate Info
Group Affiliation
None
Investment Rating
--
Company Address
4300 East Camelback Road
Phoenix, AZ 85018
Phoenix, AZ 85018
Phone Number
(602) 427-3217
NAIC Number
12625
Website
Largest Affiliates
No affiliate information available.